Evolution of Facial Assessment in Aesthetic Medicine: 3D Imaging, Digital Analysis, and Patient-Reported Outcomes.

BACKGROUND: Facial assessment is central to treatment planning and outcome evaluation. Traditional approaches, including visual inspection, manual anthropometry, and classical esthetic proportions, are limited by inter-observer variability and challenges in accounting for cultural and demographic diversity. Recent advances in digital imaging and computational analysis now enable more objective, reproducible, and clinically standardized evaluation. METHODS: This structured review employed a transparent literature search across Web of Science, PubMed, and Google Scholar to identify peer-reviewed publications published between 2020 and 2025. The aim was to provide a comprehensive overview of contemporary facial assessment technologies. The retrieved evidence was synthesized narratively and qualitatively with emphasis on clinical accuracy, reproducibility, workflow integration, and patient-reported outcome measures (PROMs). RESULTS: A large body of contemporary literature was reviewed and synthesized. The synthesized literature demonstrates a clear progression from qualitative visual assessment toward quantitative and technology-supported evaluation. Modern three-dimensional (3D) imaging systems achieve submillimeter precision, enabling reliable volumetric measurement for surgical planning and longitudinal monitoring. Automated approaches assist in grading wrinkles, pigmentation, and other aging-related features. However, important limitations remain, including inconsistent acquisition protocols, restricted demographic representation in reference datasets, and the need for clearer standards for prospective validation and workflow integration. CONCLUSION: Facial assessment in esthetic medicine is evolving toward multimodal integration of 3D volumetry, AI-driven diagnostics, and PROMs. Future clinical practice will benefit from the integration of objective morphological data with patient-reported outcomes, although developing unified platforms requires further prospective validation and real-world clinical studies. LEVEL OF EVIDENCE: Not applicable (Review Article). NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .